Luigi Mangione Tells All In His Own Words: ‘I Shot Mr. Thompson in Manhattan’

Luigi Mangione has pleaded guilty to two federal charges related to the fatal shooting of Brian Thompson, the CEO of UnitedHealthcare, in December 2024. The plea was made in a federal court in New York City on Friday, 14 August 2026, where Mangione admitted to his role in the incident that led to Thompson’s death.

During the hearing, Mangione displayed a composed demeanour and expressed his decision to plead guilty without hesitation. “I shot Mr. Thompson in Manhattan,” he stated clearly, acknowledging the illegality of his actions. He pleaded guilty to one count of interstate stalking resulting in death and another count of stalking through the use of interstate facilities, as reported by The New York Times.

In an extensive account of the circumstances leading up to the crime, Mangione elaborated on his motivations. He had endured chronic back pain and struggled with the healthcare insurance system, which ultimately drove him to research UnitedHealthcare’s annual investor conference scheduled for 4 December 2024. Posing as an investor, he managed to obtain detailed information regarding the event by emailing the company.

Before travelling to New York City, Mangione constructed a firearm using a 3-D printer and added a silencer, a detail he mentioned in his confession. This premeditated act resulted in Thompson being shot in the early hours of the investor conference outside a hotel in Midtown Manhattan. At the time of his death, Thompson was survived by his wife and their two teenage sons.

In the wake of Mangione’s guilty plea, Thompson’s family released a statement, expressing that the plea represents a critical step towards justice for both Brian and the family. The statement highlighted the ongoing anguish of losing a loved one but acknowledged gratitude towards the federal justice system for holding Mangione accountable. They urged the court to impose a sentence commensurate with the crime’s severity.

The UnitedHealth Group, the parent company of UnitedHealthcare, also issued a statement: “Brian Thompson’s life was cut short by an act of violence that devastated everyone who knew and loved him.” The company expressed appreciation for law enforcement’s efforts in bringing Thompson’s killer to justice, emphasising sympathy for the bereaved family during this challenging time.

With his recent plea, Mangione now faces a potential life sentence. Sentencing has been scheduled for 18 December 2026. Concurrently, he is also facing murder charges in a state trial set to commence with jury selection on 8 September. However, following his federal guilty plea, his defence team has filed a motion that contends the two cases infringe upon his Constitutional protection against double jeopardy.

Despite the unsuccessful attempts thus far regarding claims of double jeopardy, legal analysts have suggested that the nature of Mangione’s plea could impact the outcome. According to Seth J. Zuckerman, a New York criminal defence attorney and former prosecutor, the argument may become more robust given that Mangione has already been convicted in federal court. This development may provide grounds for halting the state trial proceedings.

Zuckerman noted that the prospect of a lengthy legal battle exists, as he anticipates challenges to the schedule ahead. He predicted that depending on the outcome of the double jeopardy motion, any adverse ruling could lead to an emergency appeal to the Appellate Division.

Since his arrest, Luigi Mangione has been held at the Metropolitan Detention Center in Brooklyn and awaits the next stages of his legal journey. As the case continues to unfold, many are watching closely for further developments in both the state and federal proceedings.